Home›Compare›altRx vs Lemonaid Health

altRx vs Lemonaid Health: Which Is Better?

Head-to-head comparison of altRx and Lemonaid Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Lemonaid Health scores higher overall in our independent evaluation (66.1/100 vs 47.6/100), leading on trust & safety, experience, product range, reputation. altRx comes out ahead on value.

48
altRx
Below Average

altRx is a Miami-operated, GLP-1-only telehealth brand advertising compounded semaglutide from $89/mo and tirzepatide from $149/mo with no separate membership fee.

Visit altRx

A long-running, broad-scope telehealth generalist now operating under new nonprofit ownership following 23andMe's 2025 bankruptcy.

Visit Lemonaid Health

Score Breakdown

DimensionaltRxLemonaid Health
Overall Score47.6/10066.1/100 ✓
Trust & Safety30%42/10062/100 ✓
Value25%70/100 ✓68/100
Experience20%35/10065/100 ✓
Product Range15%50/10080/100 ✓
Reputation10%30/10055/100 ✓

At a Glance

Founded—2013
HeadquartersMiami, FLSan Francisco, CA
Publicly tradedNoNo
Treatment categories14
Treatments listed25
Starting price$89/mo$10/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryaltRxLemonaid Health
Weight Loss / GLP-1$89–$159
Compounded Semaglutide (injectable)
$129–$399
GLP-1 Weight Loss Program

altRx

+Advertised compounded GLP-1 pricing ($89/mo semaglutide, $149/mo tirzepatide) is near the bottom of the market, with no separate membership fee
+Names its four fulfilling pharmacies (RedRock, Health Warehouse, Precision Medicine, Triad Rx) on its site
+Offers branded Wegovy, Zepbound and Ozempic prescriptions alongside compounded options
−Received an FDA warning letter (June 8, 2026) over labeling that misidentified the compounder and 'clinically proven' claims implying FDA approval
−Roughly 73-78% of Trustpilot reviews are one-star, citing undelivered refills, refused refunds, and unanswered phones and email
−Trustpilot has removed reviews on its profile for guideline breaches
Read the full altRx review →

Lemonaid Health

+Broad national telehealth generalist spanning sexual health, weight loss, hair loss, mental health, women's health and primary care under one account.
+Low-friction ED pricing: a single $25 consult covers up to 12 refills, with generic medication priced from $2/pill.
+More than a decade of operating history (founded 2013) with an established patient base and four regional medical groups providing licensed physician coverage.
−Ownership in flux: 23andMe acquired Lemonaid for roughly $400M in 2021, then filed for bankruptcy in 2025 and sold it to nonprofit TTAM Research Institute for approximately $10M — patients have no visibility into whether care continuity, medical staffing, or data handling changed under the new owner.
−Full pricing for most services beyond the advertised ED and GLP-1 offers is not published and only appears after intake.
−Trustpilot reviews cite inconsistent provider conduct, including reports of rude or dismissive clinicians and at least one unexplained prescription refusal for a long-term patient.
Read the full Lemonaid Health review →

altRx vs Lemonaid Health — FAQ

Is altRx better than Lemonaid Health?

▾

Lemonaid Health scores higher overall in our independent evaluation (66.1/100 vs 47.6/100), leading on trust & safety, experience, product range, reputation. altRx comes out ahead on value.

Is altRx or Lemonaid Health cheaper?

▾

Lemonaid Health has the lower starting price (from $10/mo vs $89/mo for altRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do altRx and Lemonaid Health both offer?

▾

Both platforms treat Weight Loss / GLP-1. altRx covers 1 treatment category total and Lemonaid Health covers 4.

Still deciding?